Covered recipient · General Payments record
FARIA ALI
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$1,519.97
- Reported across 48 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $922.42 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novocure Inc. | $146.81 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $114.32 | 3 |
| Celgene Corporation | $57.60 | 3 |
| Merck Sharp & Dohme Corporation | $55.20 | 2 |
| Lilly USA, LLC | $49.00 | 2 |
| Gilead Sciences, Inc. | $44.26 | 2 |
| PFIZER INC. | $37.35 | 2 |
| E.R. Squibb & Sons, L.L.C. | $35.29 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.57 | 1 |
| TAIHO ONCOLOGY, INC. | $29.24 | 1 |
| Deciphera Pharmaceuticals Inc. | $28.08 | 1 |
| Acrotech Biopharma Inc. | $27.30 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.77 | 1 |
| Genmab U.S., Inc. | $23.06 | 1 |
| Alnylam Pharmaceuticals Inc. | $22.16 | 1 |
| Karyopharm Therapeutics Inc. | $21.09 | 1 |
| Ipsen Biopharmaceuticals, Inc | $20.35 | 1 |
| GENZYME CORPORATION | $19.54 | 1 |
| Incyte Corporation | $19.20 | 1 |
| Rigel Pharmaceuticals, Inc. | $18.61 | 1 |
| Daiichi Sankyo Inc. | $18.38 | 1 |
| PharmaEssentia USA Corporation | $17.97 | 1 |
| Alexion Pharmaceuticals, Inc. | $16.38 | 1 |
| ARRAY BIOPHARMA INC | $16.31 | 1 |
| SpringWorks Therapeutics, Inc. | $15.79 | 1 |
| JAZZ PHARMACEUTICALS INC. | $14.79 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.